Daixing Zhou

663 total citations
23 papers, 490 citations indexed

About

Daixing Zhou is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Daixing Zhou has authored 23 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Daixing Zhou's work include Sepsis Diagnosis and Treatment (6 papers), COVID-19 Clinical Research Studies (3 papers) and Respiratory Support and Mechanisms (3 papers). Daixing Zhou is often cited by papers focused on Sepsis Diagnosis and Treatment (6 papers), COVID-19 Clinical Research Studies (3 papers) and Respiratory Support and Mechanisms (3 papers). Daixing Zhou collaborates with scholars based in China, Sweden and United States. Daixing Zhou's co-authors include Jun Feng, Shusheng Li, Junshuai Wang, Min Wang, Qiang Zhong, Fachun Zhou, Shihui Lin, Fang Xu, Qiansheng Liang and Yang Pan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Neurology and PLoS neglected tropical diseases.

In The Last Decade

Daixing Zhou

22 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daixing Zhou China 13 228 106 80 73 47 23 490
Lianhong Zou China 13 251 1.1× 38 0.4× 79 1.0× 134 1.8× 85 1.8× 43 629
Fen Yuan China 12 243 1.1× 28 0.3× 77 1.0× 86 1.2× 26 0.6× 20 670
Qi He China 17 280 1.2× 47 0.4× 104 1.3× 24 0.3× 106 2.3× 61 730
Tao Yao China 8 149 0.7× 27 0.3× 51 0.6× 30 0.4× 45 1.0× 10 434
Shenglan Yang China 9 412 1.8× 49 0.5× 70 0.9× 42 0.6× 102 2.2× 14 702
Xin Su China 14 280 1.2× 41 0.4× 38 0.5× 35 0.5× 104 2.2× 37 544
Sabariah Md Noor Malaysia 10 141 0.6× 57 0.5× 67 0.8× 21 0.3× 13 0.3× 37 557
Chihiro Sugita Japan 16 153 0.7× 22 0.2× 73 0.9× 41 0.6× 71 1.5× 35 551
Jihui Chen China 14 217 1.0× 19 0.2× 51 0.6× 37 0.5× 46 1.0× 35 536

Countries citing papers authored by Daixing Zhou

Since Specialization
Citations

This map shows the geographic impact of Daixing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daixing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daixing Zhou more than expected).

Fields of papers citing papers by Daixing Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daixing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daixing Zhou. The network helps show where Daixing Zhou may publish in the future.

Co-authorship network of co-authors of Daixing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Daixing Zhou. A scholar is included among the top collaborators of Daixing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daixing Zhou. Daixing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Cailin, et al.. (2024). 4-PBA exerts brain-protective effects against sepsis-associated encephalopathy in a mouse model of sepsis. Experimental Neurology. 375. 114738–114738. 3 indexed citations
2.
Wang, Min, Jun Feng, Daixing Zhou, & Junshuai Wang. (2023). Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis. European journal of medical research. 28(1). 339–339. 52 indexed citations
3.
Zhou, Daixing, et al.. (2023). Regulation of inflammation and immunity in sepsis by E3 ligases. Frontiers in Endocrinology. 14. 1124334–1124334. 5 indexed citations
4.
5.
Feng, Jun, Lina Liu, Yang He, et al.. (2021). Novel insights into the pathogenesis of virus-induced ARDS: review on the central role of the epithelial-endothelial barrier. Expert Review of Clinical Immunology. 17(9). 991–1001. 12 indexed citations
6.
Feng, Jun, Qin Xie, Tingrong Huang, et al.. (2021). Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial. Phytomedicine. 89. 153612–153612. 44 indexed citations
7.
Long, Lü, Lang Chen, Daixing Zhou, et al.. (2021). Effect of early oxygen therapy and antiviral treatment on disease progression in patients with COVID-19: A retrospective study of medical charts in China. PLoS neglected tropical diseases. 15(1). e0009051–e0009051. 16 indexed citations
8.
Feng, Jun, Bangjiang Fang, Daixing Zhou, et al.. (2021). Clinical Effect of Traditional Chinese Medicine Shenhuang Granule in Critically Ill Patients with COVID-19: A Single-Centered, Retrospective, Observational Study. Journal of Microbiology and Biotechnology. 31(3). 380–386. 16 indexed citations
9.
Lin, Shihui, et al.. (2020). Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome. Genes & Diseases. 7(4). 520–527. 59 indexed citations
10.
Hao, Ting, et al.. (2015). Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer. Molecular and Cellular Biochemistry. 402(1-2). 75–82. 39 indexed citations
11.
Huang, Yi, Li Zhou, Yan Li, et al.. (2015). Alpinetin inhibits lipopolysaccharide-induced acute kidney injury in mice. International Immunopharmacology. 28(2). 1003–1008. 34 indexed citations
12.
Tang, Jinhui, et al.. (2014). Effects of tanshinone IIA on the transforming growth factor β1/Smad signaling pathway in rat cardiac fibroblasts. Indian Journal of Pharmacology. 46(6). 633–633. 29 indexed citations
13.
Zhou, Daixing, et al.. (2013). PGC-1-related coactivator (PRC) negatively regulates endothelial adhesion of monocytes via inhibition of NF κB activity. Biochemical and Biophysical Research Communications. 439(1). 121–125. 13 indexed citations
14.
Zhou, Daixing, et al.. (2013). Upregulation of Sestrin-2 Expression via P53 Protects Against 1-Methyl-4-Phenylpyridinium (MPP+) Neurotoxicity. Journal of Molecular Neuroscience. 51(3). 967–975. 39 indexed citations
15.
Zhu, Wei, et al.. (2012). Protective effect of sodium tanshinone IIA sulfonate on injury of small intestine in rats with sepsis and its mechanism. Chinese Journal of Integrative Medicine. 18(7). 496–501. 16 indexed citations
16.
Zhou, Daixing, et al.. (2012). Inhibitory effect of tanshinone II A on TGF II-β1-induced cardiac fibrosis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(6). 829–833. 11 indexed citations
17.
Zhou, Daixing, et al.. (2008). Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(5). 531–534. 12 indexed citations
18.
Zhou, Daixing, et al.. (2008). [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].. PubMed. 33(8). 936–9. 4 indexed citations
19.
Yang, Le, Xiaojing Zou, Qiansheng Liang, et al.. (2007). Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway. Experimental & Molecular Medicine. 39(1). 65–73. 53 indexed citations
20.
Zhou, Daixing, et al.. (2007). [Effects of tetrandrine on Ang II-induced cardiomyocyte hypertrophy and p-ERK1/2 expression].. PubMed. 32(18). 1921–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianhong Zou Breakdown of academic impact, for papers by Fen Yuan Breakdown of academic impact, for papers by Qi He Breakdown of academic impact, for papers by Tao Yao Breakdown of academic impact, for papers by Shenglan Yang Breakdown of academic impact, for papers by Xin Su Breakdown of academic impact, for papers by Sabariah Md Noor Breakdown of academic impact, for papers by Chihiro Sugita Breakdown of academic impact, for papers by Jihui Chen
Rankless by CCL
2026